PT3279202T - Cristal de composto de alquinilo de benzeno 3,5-dissubstituído - Google Patents
Cristal de composto de alquinilo de benzeno 3,5-dissubstituídoInfo
- Publication number
- PT3279202T PT3279202T PT167732072T PT16773207T PT3279202T PT 3279202 T PT3279202 T PT 3279202T PT 167732072 T PT167732072 T PT 167732072T PT 16773207 T PT16773207 T PT 16773207T PT 3279202 T PT3279202 T PT 3279202T
- Authority
- PT
- Portugal
- Prior art keywords
- crystal
- disubstituted benzene
- alkynyl compound
- benzene alkynyl
- compound
- Prior art date
Links
- -1 3,5-disubstituted benzene alkynyl compound Chemical class 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
- C30B29/58—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015070927 | 2015-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3279202T true PT3279202T (pt) | 2020-08-31 |
Family
ID=57006122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT167732072T PT3279202T (pt) | 2015-03-31 | 2016-03-31 | Cristal de composto de alquinilo de benzeno 3,5-dissubstituído |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10434103B2 (pt) |
| EP (1) | EP3279202B1 (pt) |
| JP (2) | JP6190079B2 (pt) |
| KR (1) | KR101917557B1 (pt) |
| CN (2) | CN111393446B (pt) |
| AU (1) | AU2016240841C1 (pt) |
| CA (1) | CA2980888C (pt) |
| DK (1) | DK3279202T3 (pt) |
| ES (1) | ES2812785T3 (pt) |
| HK (1) | HK1246297A1 (pt) |
| HU (1) | HUE051074T2 (pt) |
| MX (1) | MX2017012568A (pt) |
| MY (1) | MY196077A (pt) |
| PH (1) | PH12017501690A1 (pt) |
| PL (1) | PL3279202T3 (pt) |
| PT (1) | PT3279202T (pt) |
| RU (1) | RU2672563C1 (pt) |
| SG (1) | SG11201707384YA (pt) |
| WO (1) | WO2016159327A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3023101B1 (en) | 2013-07-18 | 2020-08-19 | Taiho Pharmaceutical Co., Ltd. | Therapeutic agent for fgfr inhibitor-resistant cancer |
| TR201907147T4 (tr) | 2013-07-18 | 2019-06-21 | Taiho Pharmaceutical Co Ltd | Fgfr inhibitörünün aralıklı uygulanmasına yönelik anti-tümör ilaç. |
| AU2016240841C1 (en) | 2015-03-31 | 2018-05-17 | Taiho Pharmaceutical Co., Ltd. | Crystal of 3,5-disubstituted benzene alkynyl compound |
| US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
| AU2017226389B2 (en) | 2016-03-04 | 2023-02-02 | Taiho Pharmaceutical Co., Ltd. | Preparation and composition for treatment of malignant tumors |
| PL3769765T3 (pl) | 2018-03-19 | 2024-06-10 | Taiho Pharmaceutical Co., Ltd. | Kompozycja farmaceutyczna zawierająca alkilosiarczan sodu |
| WO2020096042A1 (ja) | 2018-11-09 | 2020-05-14 | 大鵬薬品工業株式会社 | ジメトキシベンゼン化合物の製造方法 |
| WO2020095452A1 (ja) | 2018-11-09 | 2020-05-14 | 大鵬薬品工業株式会社 | ジメトキシベンゼン化合物の製造方法 |
| TWI791928B (zh) * | 2018-11-26 | 2023-02-11 | 日商大鵬藥品工業股份有限公司 | 透過併用纖維母細胞生長因子受體抑制劑與內分泌療法來治療及預防可適用內分泌療法之腫瘤的方法 |
| WO2020170355A1 (ja) * | 2019-02-20 | 2020-08-27 | 大鵬薬品工業株式会社 | Ｆｇｆｒ１変異腫瘍の治療方法 |
| JP2022533939A (ja) * | 2019-05-17 | 2022-07-27 | キネート バイオファーマ インク． | 線維芽細胞増殖因子受容体キナーゼの阻害剤 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2624882C (en) | 2005-10-06 | 2014-05-20 | Schering Corporation | Pyrazolopyrimidines as protein kinase inhibitors |
| US8648087B2 (en) | 2005-11-15 | 2014-02-11 | Array Biopharma, Inc. | N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| JP5156644B2 (ja) | 2006-01-25 | 2013-03-06 | オーエスアイ・フアーマシユーテイカルズ・エル・エル・シー | 不飽和ｍＴＯＲ阻害剤 |
| EP1939197A1 (en) | 2006-12-22 | 2008-07-02 | Schwarz Pharma Ag | 8-ethinylxanthine derivatives as selective A2A receptor antagonists |
| CA2681756C (en) | 2007-03-28 | 2015-02-24 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
| AU2009261683A1 (en) | 2008-06-19 | 2009-12-23 | Astrazeneca Ab | Pyrazole compounds 436 |
| GB0819105D0 (en) | 2008-10-17 | 2008-11-26 | Chroma Therapeutics Ltd | Pyrrolo-pyrimidine compounds |
| CA2759083A1 (en) | 2009-04-30 | 2010-11-04 | Novartis Ag | Imidazole derivatives and their use as modulators of cyclin dependent kinases |
| KR101483215B1 (ko) | 2010-01-29 | 2015-01-16 | 한미약품 주식회사 | 단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체 |
| EP2547698B1 (en) | 2010-03-14 | 2015-07-29 | The Translational Genomics Research Institute | Methods of determining susceptibility of tumors to tyrosine kinase inhibitors |
| DE102011015188A1 (de) | 2010-03-29 | 2011-09-29 | Herbert Kannegiesser Gmbh | Verfahren zur Nassbehandlung, insbesondere zum Reinigen, von Gegenständen |
| CA3240281A1 (en) | 2010-06-03 | 2011-12-08 | Pharmacyclics Llc | Use of inhibitors of bruton's tyrosine kinase (btk) in the treatment of follicular lymphoma |
| MX342064B (es) | 2011-04-06 | 2016-09-12 | Taiho Pharmaceutical Co Ltd | Novedoso compuesto de imidazo-oxazina o sal del mismo. |
| EP2657233B1 (en) | 2012-01-19 | 2014-08-27 | Taiho Pharmaceutical Co., Ltd. | 3,5-disubstituted alkynylbenzene compound and salt thereof |
| SG11201402876UA (en) * | 2012-02-23 | 2014-12-30 | Taiho Pharmaceutical Co Ltd | Quinolylpyrrolopyrimidyl fused-ring compound or salt thereof |
| CN103570725B (zh) | 2012-08-01 | 2017-03-22 | 中国科学院上海药物研究所 | 哌嗪并三唑类化合物及其制备方法和用途 |
| JP2016510751A (ja) | 2013-03-06 | 2016-04-11 | ジェネンテック， インコーポレイテッド | 抗がん剤耐性を治療及び予防する方法 |
| CN109776525B (zh) | 2013-04-19 | 2022-01-21 | 因赛特控股公司 | 作为fgfr抑制剂的双环杂环 |
| EP3023101B1 (en) * | 2013-07-18 | 2020-08-19 | Taiho Pharmaceutical Co., Ltd. | Therapeutic agent for fgfr inhibitor-resistant cancer |
| TR201907147T4 (tr) * | 2013-07-18 | 2019-06-21 | Taiho Pharmaceutical Co Ltd | Fgfr inhibitörünün aralıklı uygulanmasına yönelik anti-tümör ilaç. |
| WO2015163448A1 (ja) | 2014-04-25 | 2015-10-29 | 中外製薬株式会社 | ４環性化合物を高用量含有する製剤 |
| AU2016240841C1 (en) | 2015-03-31 | 2018-05-17 | Taiho Pharmaceutical Co., Ltd. | Crystal of 3,5-disubstituted benzene alkynyl compound |
| AU2017226389B2 (en) | 2016-03-04 | 2023-02-02 | Taiho Pharmaceutical Co., Ltd. | Preparation and composition for treatment of malignant tumors |
-
2016
- 2016-03-31 AU AU2016240841A patent/AU2016240841C1/en active Active
- 2016-03-31 MY MYPI2017703525A patent/MY196077A/en unknown
- 2016-03-31 PL PL16773207T patent/PL3279202T3/pl unknown
- 2016-03-31 EP EP16773207.2A patent/EP3279202B1/en active Active
- 2016-03-31 CN CN202010284155.8A patent/CN111393446B/zh active Active
- 2016-03-31 CN CN201680019829.3A patent/CN107406455B/zh active Active
- 2016-03-31 WO PCT/JP2016/060844 patent/WO2016159327A1/ja active Application Filing
- 2016-03-31 PT PT167732072T patent/PT3279202T/pt unknown
- 2016-03-31 ES ES16773207T patent/ES2812785T3/es active Active
- 2016-03-31 US US15/562,455 patent/US10434103B2/en active Active
- 2016-03-31 RU RU2017134584A patent/RU2672563C1/ru active
- 2016-03-31 DK DK16773207.2T patent/DK3279202T3/da active
- 2016-03-31 MX MX2017012568A patent/MX2017012568A/es active IP Right Grant
- 2016-03-31 KR KR1020177030951A patent/KR101917557B1/ko active IP Right Grant
- 2016-03-31 JP JP2016566309A patent/JP6190079B2/ja active Active
- 2016-03-31 HU HUE16773207A patent/HUE051074T2/hu unknown
- 2016-03-31 CA CA2980888A patent/CA2980888C/en active Active
- 2016-03-31 SG SG11201707384YA patent/SG11201707384YA/en unknown
-
2017
- 2017-08-02 JP JP2017149671A patent/JP2017193581A/ja active Pending
- 2017-09-15 PH PH12017501690A patent/PH12017501690A1/en unknown
-
2018
- 2018-05-08 HK HK18105931.1A patent/HK1246297A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016240841C1 (en) | 2018-05-17 |
| PL3279202T3 (pl) | 2020-12-28 |
| EP3279202A4 (en) | 2018-08-22 |
| DK3279202T3 (da) | 2020-08-17 |
| JPWO2016159327A1 (ja) | 2017-04-27 |
| PH12017501690A1 (en) | 2018-03-19 |
| WO2016159327A1 (ja) | 2016-10-06 |
| MY196077A (en) | 2023-03-13 |
| US10434103B2 (en) | 2019-10-08 |
| KR20170132251A (ko) | 2017-12-01 |
| RU2672563C1 (ru) | 2018-11-16 |
| MX2017012568A (es) | 2018-01-25 |
| KR101917557B1 (ko) | 2018-11-09 |
| JP6190079B2 (ja) | 2017-08-30 |
| CA2980888A1 (en) | 2016-10-06 |
| CN111393446A (zh) | 2020-07-10 |
| ES2812785T3 (es) | 2021-03-18 |
| CA2980888C (en) | 2018-03-06 |
| CN107406455B (zh) | 2020-05-12 |
| CN107406455A (zh) | 2017-11-28 |
| JP2017193581A (ja) | 2017-10-26 |
| AU2016240841A1 (en) | 2017-10-05 |
| CN111393446B (zh) | 2022-12-20 |
| AU2016240841B2 (en) | 2018-02-01 |
| EP3279202A1 (en) | 2018-02-07 |
| SG11201707384YA (en) | 2017-10-30 |
| HUE051074T2 (hu) | 2021-03-01 |
| HK1246297A1 (zh) | 2018-09-07 |
| US20180110782A1 (en) | 2018-04-26 |
| BR112017019809A2 (pt) | 2018-05-29 |
| EP3279202B1 (en) | 2020-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1246297A1 (zh) | 3，5-二取代的苯炔基化合物晶體 | |
| EP3372604A4 (en) | CONDENSED HETEROCYCLIC COMPOUND | |
| HK1256825A1 (zh) | 取代的5，6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式 | |
| EP3375783A4 (en) | CONDENSED HETEROCYCLIC COMPOUND | |
| GB201702947D0 (en) | Novel compounds | |
| GB201717530D0 (en) | New compounds | |
| GB201714049D0 (en) | New compounds | |
| GB201712289D0 (en) | New compounds | |
| GB201718561D0 (en) | Novel compounds | |
| GB201718563D0 (en) | Novel compounds | |
| GB201716131D0 (en) | Novel compounds | |
| GB201714699D0 (en) | Novel compounds | |
| GB201713082D0 (en) | Novel compounds | |
| GB201713083D0 (en) | Novel compounds | |
| GB201713085D0 (en) | Novel compounds | |
| GB201713079D0 (en) | Novel Compounds | |
| GB201713076D0 (en) | Novel compounds | |
| GB201711682D0 (en) | Novel compounds | |
| GB201711549D0 (en) | Novel compounds | |
| GB201710943D0 (en) | Novel Compounds | |
| GB201710942D0 (en) | Novel compounds | |
| GB201710331D0 (en) | Novel compounds | |
| GB201709919D0 (en) | Novel compounds | |
| GB201709824D0 (en) | Novel Compounds | |
| GB201702725D0 (en) | New compounds |